BIO-tract® probiotic delivery system now patented in 33 countries

News provided by

Nutraceutix

10 Sep, 2013, 14:23 GMT

- Patents in 24 European countries add to those in Asia and North America.

- Worldwide validation for dietary supplement technology that protects probiotics from stomach acid and provides controlled, extended release of live organisms to the intestines.

REDMOND, Washington, Sept. 10, 2013 /PRNewswire/ -- Patents have now been granted in more than 30 countries for Nutraceutix's "Delivery System for Biological Component", trademarked as BIO-tract®. This now includes the 24 countries in the European Patent Convention, in addition to Australia, Canada, Singapore, Japan, Hong Kong, Republic of Korea, People's Republic of China, the Russian Federation and the United States. Additional patents in the U.S. and Canada are pending.

(Photo: http://photos.prnewswire.com/prnh/20130910/SF75469)

Continue Reading
This image opens in the lightbox
Stomach acids can destroy probiotics before they reach the intestinal tract where they do their good work. BIO-tract(R) tablets protect probiotics and other ingredients from gastric acid, and offer controlled-release to optimize ingredient delivery over time.Here's how it works: When moistened by fluids in the stomach, a protective layer forms to help shield contents from gastric acid and enzymes. As the tablet moves through the gastrointestinal tract, contents are gradually released at rates determined by formulation. Nutraceutix now holds more than 30 international patents for this novel dietary supplement delivery technology. (PRNewsFoto/Nutraceutix) (PRNewsFoto/NUTRACEUTIX)

(Logo: http://photos.prnewswire.com/prnh/20111006/SF81647LOGO)

The European Patent Convention includes: Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, The Netherlands, Portugal, Slovakia, Spain, Sweden, Switzerland, Turkey, and the United Kingdom.

Unlike powders, capsules and cultured foods, BIO-tract tablets offer protection from damaging stomach acids, then gently release live organisms over time to the upper and lower intestinal tracts for heightened effectiveness. BIO-tract also takes advantage of Nutraceutix's patented LiveBac® processing to extend probiotic shelf life far beyond other supplemental forms, even at room temperature.

"Our growing, global patent portfolio documents BIO-tract's technical superiority," asserts Tim Gamble, President and CEO of Nutraceutix. "For years, BIO-tract has been a recognized hallmark of quality and is now becoming the industry standard for premium probiotics and other ingredients that benefit from its unique capabilities. It is the only probiotic dietary supplement format that offers such a stellar combination of effective delivery and stability with outstanding formulation and packaging flexibility."

About Nutraceutix

Headquartered in Redmond, Washington, Nutraceutix is an NSF Certified GMP contract manufacturer and private labeler of probiotics and other premium nutritional supplements. The company specializes in producing high-quality probiotics in bulk powder, capsules and tablets from its broad, factory-direct offering of natural probiotic organisms. Nutraceutix's pioneering achievements and unequalled collection of patented processes and technology were recognized by Frost and Sullivan in 2010 with a North American "Technology Innovation of the Year" award.